Group items tagged

Creative BioLabs is an US based biotech service provider.It has extensive experience in fully human monoclonal antibody. Call 1-631-871-5806 or email at contact@creative-biolabs.com for details. Learn more by visiting http://www.creative-biolabs.com/full-human-antibody-from-humanized-mouse-derived-antibody-library.html. Creative Biolabs are pleased to introduce our full human antibody from humanized mouse-derived antibody library service, we have successfully produced several functional libraries.

Antibody sequencing is a technique focuses on the determination of the amino acid sequence of an antibody, as well as which conformation the antibody adopts and the extent to which it is complexed with any non-peptide molecules.

Creative BioLabs is an US based biotech service provider.It has extensive experience in igY antibody generation. Call 1-631-871-5806 or email at contact@creative-biolabs.com for details. Learn more by visiting http://www.creative-biolabs.com/igY-antibody-generation.html.

Creative BioLabs is an US based biotech service provider.It has extensive experience in anti-idiotypic antibody . Call 1-631-871-5806 or email at contact@creative-biolabs.com for details. Learn more by visiting http://www.creative-biolabs.com/Production-of-Anti-idiotype-Antibody.html.

Fragment antibody-binding (Fab fragment) is a region on an antibody that binds to antigens. It is composed of one constant and one variable domain of each of the heavy and the light chain. Single-chain variable fragment (scFv) is not actually a fragment of an antibody, but instead is a fusion protein of the variable regions of the heavy (VH) and light chains (VL) of immunoglobulins, connected with a short linker peptide of ten to about 25 amino acids.

Based on the traditional methods and developed "database assisted shotgun sequencing" (DASS) technology, Creative Biolabs announces de novo antibody sequencing service for research, diagnostic and therapeutic industries.

In part I of antobody engineering, IgG construction has introduced, apart from which there are another two that antibody engineers focused much of their efforts on, antibody stability improvement and scFv/Fab construction.

PHILADELPHIA - Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.

Creative BioLabs is an US based biotech service provider.It has extensive experience in internalizing antibody and peptides. Call 1-631-871-5806 or email at contact@creative-biolabs.com for details.

Along with information technology, biotechnology is the greatest motivator for global economic development in the 21 century. It is maturing into the leading technology that may reshape the pattern of future industry as well as economy. Following up biotechnology's continuously building itself, antibody engineering, the main force of biotechnology industrialization, has earned itself an important place in this field, bio-pharmacy in particular.

February 14, 2009 - (BRONX, NY) - Scientists at Albert Einstein College of Medicine of Yeshiva University have piggybacked antibodies onto radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected cells. The experimental treatment - called radioimmunotherapy, or RIT - holds promise for treating various infectious diseases, including HIV and cancers caused by viruses. The research was presented today at the annual meeting of the American Association for the Advancement of Science (AAAS), the world's largest general scientific society and the publishers of the journal Science.

Cancer immunology is the study of interactions between the immune system and cancer cells (also called tumors or malignancies). It is also a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of this disease. The immune response, including the recognition of cancer-specific antigens is of particular interest in this field as knowledge gained drives the development of new vaccines and antibody therapies. For instance in 2007, Ohtani published a paper finding tumour infiltrating lymphocytes to be quite significant in human colorectal cancer.[1] The host was given a better chance at survival if the cancer tissue showed infiltration of inflammatory cells, in particular lymphocytic reactions. The results yielded suggest some extent of anti-tumour immunity is present in colorectal cancers in humans.

Age, stress, and poor nutrition can sap our immune system of its effectiveness. Influenza provides one example. During young adulthood, when the body can mount a robust immune response to this common virus, influenza is rarely fatal. Among the elderly, however, the virus is associated with significant rates of death and hospitalization (Nichol KL 2005). The impact of aging on the immune system is profound. As people age, a number of critical immune system components are reduced or slowed, including cellular response, response to vaccines, and antibody production. At the same time, susceptibilities to infection and cancer are increased. Some of this increased susceptibility to disease is linked to chronic inflammation, which is associated with many disorders of aging (Ershler WB et al 2000; Hamerman D 1999; Taaffe DR et al 2000).

Can sniffer dog detection take the place of traditional prostate cancer screening like immunized human antibody library ? It is still too early to draw a conclusion at present. Nobody knows how this sniffer dog detection technology can be applied to clinical use, or whether it can be widely promoted.